Federal Bill C‑17 (known as Vanessa’s Law) comes into force on December 16, 2019.

The law amends Canada’s Food and Drug Act by adding the following requirement:

“21.8 A prescribed health care institution shall provide the Minister, within the prescribed time and in the prescribed manner, with prescribed information that is in its control about a serious adverse drug reaction that involves a therapeutic product or a medical device incident that involves a therapeutic product.”

For more information about Vanessa’s law, there are helpful resources here.